Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial

Michael A. Pulsipher, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, William L. Carroll, Elizabeth Raetz, Sharon Gardner, Julie M. Gastier-Foster, Denise Howrie, Rakesh K. Goyal, James G. Douglas, Michael Borowitz, Yvonne Barnes, David T. Teachey, Candace Taylor, Stephan A. Grupp

Blood (2014) 123 (13): 2017–2025.

https://doi.org/10.1182/blood-2013-10-534297

Published: 2014

Journal Articles

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, Julie M. Gastier-Foster, PhD, Michael J. Borowitz, MD, PhD, Rakesh Goyal, MD, MRCP, Sharon Gardner, MD, William L. Carroll, MD, Elizabeth Raetz, MD, Stephan A. Grupp, MD, PhD

Blood (2012) 120 (21): 470.

https://doi.org/10.1182/blood.V120.21.470.470

Published: 2012

Journal Articles

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Sharon Gardner, MD, Julie M. Gastier-Foster, PhD, Denise Howrie, PharmD, Rakesh Goyal, MD, MRCP, Douglas James, MD, MRCP, Michael J. Borowitz, MD, PhD, Yvonne Jean Barnes, RN MSN CPNP, Shivanand R. Patil, PhD, David T Teachey, MD, Candace Taylor, CCRP, Stephan A Grupp, MD, PhD

Blood (2011) 118 (21): 837.

https://doi.org/10.1182/blood.V118.21.837.837

Published: 2011

Journal Articles

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Shirley Hogan, PharmD, Joy Mitchell, CRA, Vickie Massey, MD, Louis S. Constine, MD, Lu Chen, PhD, Cindy L. Schwartz, MD

Blood (2007) 110 (11): 1896.

https://doi.org/10.1182/blood.V110.11.1896.1896

Published: 2007

Journal Articles

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen Chen, MD, PhD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Robert Guillerman, MD, Shirley Hogan, PharmD, Joy Mitchell, Alan Gamis, MD, Vicki Massey, MD, Louis S. Constine, MD, Doojduen Villaluna, MS, Richard Sposto, MD, Cindy Schwartz, MD

Blood (2005) 106 (11): 2087.

https://doi.org/10.1182/blood.V106.11.2087.2087

Published: 2005

Journal Articles

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Tanya Trippett, M.D., Pedro De Alarcon, M.D., Wendy London, Ph.D., Richard Sposto, Ph.D., Allen Chen, M.D., Sharon Gardner, M.D., Cindy Schwartz, M.D.

Blood (2004) 104 (11): 2496.

https://doi.org/10.1182/blood.V104.11.2496.2496

Published: 2004

NARROW

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Email alerts

ASH Publications

American Society of Hematology

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only